RSSReview

Advances in Vitiligo: An Update on Medical and Surgical Treatments

| January 1, 2017

Alexander B. Dillon, MD; Andrew Sideris, MSc; Ali Hadi, BA; Nada Elbuluk, MD, MSc* The Ronald O. Perelman Department of Dermatology, New York University, New York, New York Disclosure: The authors report no relevant conflicts of interest. Abstract Vitiligo is one of the most common cutaneous disorders of depigmentation. Although its underlying causes are still […]

Continue Reading

Emerging Issues in Adult Female Acne

| January 1, 2017

aJoshua A. Zeichner, MD; bHillary E. Baldwin, MD; cFran E. Cook-Bolden, MD; dLawrence F. Eichenfield, MD; dSheila Fallon-Friedlander, MD; eDavid A. Rodriguez, MD aMount Sinai Hospital, New York, New York bMorristown, New Jersey cSkin Specialty Dermatology, New York, New York dUniversity of California, Rady Children’s Hospital, San Diego, California eDermatology Associates/Research, Coral Gables, Florida; cRedwood […]

Continue Reading

Multivesicular Emulsion Ceramide-containing Moisturizers: An Evaluation of Their Role in the Management of Common Skin Disorders

| December 1, 2016

aJoshua A. Zeichner, MD; bJames Q. Del Rosso, DO aDepartment of Dermatology, Mount Sinai Hospital, New York, New York bTouro University Nevada, Henderson, Nevada; Lakes Dermatology and Del Rosso Dermatology Research, Las Vegas, Nevada Disclosure: Dr. Del Rosso is a consultant, researcher, and/or speaker for Aqua/Amirall, Bayer Dermatology, BioPharmX, Celgene, Cutanea, Dermira, Ferndale, Foamix, Galderma, […]

Continue Reading

Nonsurgical Cosmetic Procedures For Men: Trends And Technique Considerations

| December 1, 2016

aCorey S. Frucht, MD, PhD; bArisa E. Ortiz, MD aSanta Barbara Skin Care, Santa Barbara, California; bDepartment of Dermatology, University of California, San Diego, San Diego, California Disclosure: Dr. Frucht reports no relevant conflicts of interest. Dr. Ortiz is an Allergan stockholder; has received equipment loans from Zeltiq, Sciton, Solta, Inmode, and BTL; and is […]

Continue Reading

Injection Adipolysis: Mechanisms, Agents, and Future Directions

| December 1, 2016

aShahraam Kamalpour, MD; a,bKeith LeBlanc Jr., MD aLouisiana State University Dermatology, New Orleans, Louisiana; bSkin Surgery Centre, Metairie and Mandeville, Louisiana Disclosure: The authors report no relevant conflicts of interest. Abstract Noninvasive procedures targeting the elimination of unwanted adipose tissues have recently been developed. Injection adipolysis is the term for the injection of cytotoxic substances […]

Continue Reading

High-dose Rate Electronic Brachytherapy: A Nonsurgical Treatment Alternative for Nonmelanoma Skin Cancer

| November 1, 2016

aAjay Bhatnagar, MD, MBA; bRakesh Patel, MD; cWilliam Philip Werschler, MD; dRoger I. Ceilley, MD; eRobert Strimling, MD a21st Century Oncology, Casa Grande, Arizona bValley Medical Oncology Consultants, Pleasanton, California cSpokane Dermatology Clinic, Spokane, Washington dDermatology, P.C., West Des Moines, Iowa eStrimling Dermatology, Laser, and Vein Institute, Las Vegas, Nevada Disclosure: Dr. Bhatnagar is a […]

Continue Reading

Topical Treatment for Onychomycosis: Is it More Effective than the Clinical Data Suggests?

| November 1, 2016

aBoni E Elewski, MD; bTracey C. Vlahovic, DPM; cAndrew Korotzer, PhD aDepartment of Dermatology, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama bTemple University School of Podiatric Medicine, Philadelphia, Pennsylvania cValeant Pharmaceuticals North America LLC, Bridgewater, New Jersey Disclosure: Dr Elewski is an advisor for Valeant Pharmaceuticals and investigator for Valeant Pharmaceuticals and […]

Continue Reading